Lipoxygenases in chronic liver diseases: current insights and future perspectives

被引:7
|
作者
Heinrich, Lena [1 ]
Booijink, Richell [1 ]
Khurana, Amit [1 ,2 ,3 ]
Weiskirchen, Ralf [2 ]
Bansal, Ruchi [1 ]
机构
[1] Univ Twente, Fac Sci & Technol, Tech Med Ctr, Dept Med Cell BioPhys,Translat Liver Res, NL-7500 AE Enschede, Netherlands
[2] Rhein Westfalische TH RWTH Univ Hosp Aachen, Inst Mol Pathobiochem Expt Gene Therapy & Clin Ch, D-52074 Aachen, Germany
[3] Indian Inst Technol IIT, Ctr Biomed Engn CBME, New Delhi 110016, India
关键词
NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; LINOLEIC-ACID; FATTY-ACIDS; INJURY; METABOLITES; CELLS; MICE; INHIBITION; RECEPTOR;
D O I
10.1016/j.tips.2021.12.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic liver diseases (CLDs) caused by viral infections, alcohol/drug abuse, or metabolic disorders affect millions of people globally and have increased mortality owing to the lack of approved therapies. Lipoxygenases (LOXs) are a family of multifaceted enzymes that are responsible for the oxidation of polyunsaturated fatty acids (PUFAs) and are implicated in the pathogenesis of multiple disorders including liver diseases. This review describes the three main LOX signaling pathways - 5-, 12-, and 15-LOX - and their involvement in CLDs. We also provide recent insights and future perspectives on LOX-related hepatic pathophysiology, and discuss the potential of LOXs and LOX-derived metabolites as diagnostic biomarkers and therapeutic targets in CLDs.
引用
收藏
页码:188 / 205
页数:18
相关论文
共 50 条
  • [41] Registries of rare diseases: current knowledge and future perspectives
    Elena Gelain
    Michelangelo Tesi
    Martina Mazzariol
    Augusto Vaglio
    Internal and Emergency Medicine, 2023, 18 : 19 - 21
  • [42] ON THE SUBJECT OF AVIAN DISEASES - CURRENT SITUATION AND FUTURE PERSPECTIVES
    KOSTERS, J
    JAKOBY, JR
    DEUTSCHE TIERARZTLICHE WOCHENSCHRIFT, 1986, 93 (01): : 42 - 44
  • [43] Phenotypes of Cardiovascular Diseases: Current Status and Future Perspectives
    Hang Zhang
    Xiumeng Hua
    Jiangping Song
    Phenomics, 2021, 1 : 229 - 241
  • [44] Registries of rare diseases: current knowledge and future perspectives
    Gelain, Elena
    Tesi, Michelangelo
    Mazzariol, Martina
    Vaglio, Augusto
    INTERNAL AND EMERGENCY MEDICINE, 2023, 18 (01) : 19 - 21
  • [45] Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives
    Gallo, Antonella
    Lipari, Alice
    Di Francesco, Silvino
    Ianua, Eleonora
    Liperoti, Rosa
    Cipriani, Maria Camilla
    Martone, Anna Maria
    De Candia, Erica
    Landi, Francesco
    Montalto, Massimo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [46] Chrononutrition in cardiometabolic diseases: Current evidence and future perspectives
    Carbone, Salvatore
    Pozzilli, Paolo
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (02)
  • [47] Phenotypes of Cardiovascular Diseases: Current Status and Future Perspectives
    Zhang, Hang
    Hua, Xiumeng
    Song, Jiangping
    PHENOMICS, 2021, 1 (05): : 229 - 241
  • [48] Stem Cell Therapy for Liver Diseases: Current Perspectives
    Wang, Jing
    Li, Qun
    Li, Wenbo
    Mendez-Sanchez, Nahum
    Liu, Xiaofeng
    Qi, Xingshun
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (12): : 359
  • [49] Australasian Insights and Perspectives on the Burden of Chronic Liver Disease
    Zhou, Annie
    Sawhney, Rohit
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (04) : 907 - 908
  • [50] Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives
    Diego García-Compeán
    Emanuela Orsi
    Ramesh Kumar
    Felix Gundling
    Tsutomu Nishida
    Jesús Zacarías Villarreal-Pérez
    ángel N Del Cueto-Aguilera
    José A González-González
    Giuseppe Pugliese
    World Journal of Gastroenterology, 2022, 28 (08) : 775 - 793